Biliary Tract Neoplasms
📧 Sign up to get email alerts when something new happens for Biliary Tract Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-16EMA Authorised: Ziihera (zanidatamab) — Jazz Pharmaceuticals Ireland Limited
ZaniDatamab (zanidatamab) has been authorised by EMA for biliary tract neoplasms with conditional approval and orphan designation.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Impact of Intraoperative PTCD Catheter Retention Versus Removal on Postoperative Short-term Outcomes After Pancreaticoduodenectomy in Obstructive Jaundice [NA]
This clinical trial update notes a study evaluating intraoperative retention versus removal of a PTCD catheter during pancreaticoduodenectom…
-
EMA approval · 2025-12-17EMA Authorised: Ziihera (zanidatamab) — Jazz Pharmaceuticals Ireland Limited
EMA authorised zanidatamab (Ziihera) for biliary tract neoplasms under conditional approval and orphan medicine designation.
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope [NA]
Clinical trial comparing a single-use distal-covered duodenoscope with a conventional reusable duodenoscope in biliary and pancreatic diseas…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial) [NA]
A clinical trial comparing EUS-guided choledochoduodenostomy versus ERCP as first-line treatment for malignant distal biliary obstruction is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial) [NA]
The CARPEGIEM trial is recruiting to compare endoscopic ultrasound-guided gallbladder drainage versus CDS as first-line palliation for malig…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy [NA]
A randomized trial comparing two surgical techniques for pancreaticojejunostomy during pancreaticoduodenectomy has been terminated.
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Personalized Medicine for Advanced Biliary Cancer Patients [Phase 3]
This clinical trial update notes a Phase 3 study investigating personalized medicine for advanced biliary cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer [Phase 2]
This Phase 2 trial evaluates neoadjuvant gemcitabine plus cisplatin, with or without durvalumab, in patients with resectable biliary tract c…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics [NA]
Clinical trial registry entry describing an ongoing targeted-agent evaluation in digestive cancers in China based on molecular characteristi…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating Durvalumab (MEDI4736) and Tremelimumab with gemcitabine/cisplatin in chemotherapy-naïve biliary tract cancer (activ…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC). [Phase 2]
Phase 2 trial evaluating trametinib plus hydroxychloroquine in KRAS-mutant biliary tract cancers was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract Cancer [Phase 2]
Phase 2 trial update for TST001 in CLDN18.2-positive biliary tract cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors [Phase 2]
Phase 2 trial evaluating axitinib plus toripalimab as second-line therapy for hepatobiliary neoplasms and liver neoplasms.
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) [Phase 2]
Phase 2 pilot study evaluating combined immune checkpoint inhibition with ablative therapies in hepatocellular carcinoma and biliary tract c…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer [Phase 2]
A Phase 2 trial evaluating nivolumab with gemcitabine/cisplatin or with ipilimumab for advanced unresectable biliary tract cancer has comple…
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with CAPOX for advanced biliary tract cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-04-17Clinical Trial Update: Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural [Phase 2]
Phase 2 trial comparing intravenous versus patient-controlled epidural analgesia after pancreatobiliary surgery in pancreatic cancer and bil…
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers [Phase 2]
Phase 2 study of nivolumab in patients with advanced refractory biliary tract cancers has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Tremelimumab With Chemoembolization or Ablation for Liver Cancer [Phase 1, Phase 2]
Phase 1/2 trial exploring tremelimumab combined with chemoembolization or ablation for liver cancers has completed enrollment with results p…
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: The Effect of Individualized Precision Therapy Programs in Patients With BTC [Phase 4]
Phase 4 clinical trial update evaluating individualized precision therapy programs in patients with biliary tract neoplasms.
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial comparing second-line irinotecan and capecitabine versus irinotecan for biliary tract cancer after gemcitabine and ci…
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Apatinib for Advanced Biliary Carcinoma [Phase 2]
Phase 2 clinical trial update for apatinib in advanced biliary tract neoplasms (biliary carcinoma).
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: MRCP Diagnoses EHCC Better When Combined DWI [NA]
A completed clinical trial indicates that using MRCP in combination with diffusion-weighted imaging improves the diagnostic accuracy for ext…
-
CLINICAL_TRIALS research · 2017-02-24Clinical Trial Update: EUS BD vs ERCP TP for Pancreatic Cancer [NA]
A clinical trial comparing endoscopic ultrasound-guided biliary drainage to ERCP-based therapy for pancreatic cancer; the trial status is cu…